NCT02553967 2026-03-17
REMASCO
Centre Oscar Lambret
Phase NA Completed
Clinical Trials
46 trialsNCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT07416825 2026-02-18
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Institute of Oncology Ljubljana
Phase NA Completed
NCT04447027 2026-01-30
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02356159 2025-09-30
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01879657 2025-08-06
68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
Radio Isotope Therapy of America
Phase NA Completed
NCT04227717 2025-07-18
Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00001337 2025-06-22
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03448393 2025-06-04
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04685928 2025-05-06
SMART
Chinese University of Hong Kong
Phase NA Completed
NCT03092518 2025-02-19
Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04599634 2025-02-04
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03482557 2025-01-09
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
Beth Israel Deaconess Medical Center
Phase NA Completed
NCT02163317 2024-05-10
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT04219969 2024-05-09
FDG PET-MRI for the Diagnosis of Spinal Cord Lesions
M.D. Anderson Cancer Center
Phase NA Completed
NCT03508765 2024-03-08
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03188354 2024-01-05
Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma
Norwegian University of Science and Technology
Phase NA Completed
NCT06016335 2023-12-19
MRI-based Synthetic CT Images of the Head and Neck
Amsterdam UMC, location VUmc
Phase NA Completed
NCT05727007 2023-10-10
CT and MRI in Preoperative Colon Cancer Staging
Larissa University Hospital
Phase NA Completed
NCT02683824 2023-09-21
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
Stanford University
Phase EARLY_PHASE1 Completed
NCT03702556 2023-08-24
Functional MRI Study Reconstructed Breasts
Maastricht University Medical Center
Phase NA Completed
NCT02681614 2022-06-30
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
Case Comprehensive Cancer Center
Phase NA Completed
NCT03436901 2022-01-03
TENY
Aarhus University Hospital
Phase NA Completed
NCT03125629 2021-04-09
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Stanford University
Phase 2 Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT02903784 2020-09-02
BNL
University Hospital, Montpellier
Phase NA Completed
NCT02581839 2020-07-30
Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Case Comprehensive Cancer Center
Phase 2 Completed
NCT01871545 2020-07-09
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT02662166 2020-06-17
MIB
Turku University Hospital
Phase NA Completed
NCT02246231 2020-03-17
Effect of Implant Position on Magnetic Resonance Image Distortion
Manchester University NHS Foundation Trust
Phase NA Completed
NCT02488096 2020-01-21
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
Saskatchewan Health Authority - Regina Area
Phase NA Completed
NCT02470910 2019-12-11
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Dana-Farber Cancer Institute
Phase NA Completed
NCT02084147 2019-10-29
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Case Comprehensive Cancer Center
Phase NA Completed
NCT00003302 2019-09-25
MRI to Detect Breast Tumors in Women
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT02141490 2019-09-06
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02786459 2019-06-03
ProxiScan
University Health Network, Toronto
Phase NA Completed
NCT02767609 2019-04-30
Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
Loma Linda University
Phase NA Completed
NCT02717572 2019-04-05
18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR
Washington University School of Medicine
Phase 1 Completed
NCT02391493 2018-03-27
NEUROSWITCH
University Hospital, Toulouse
Phase NA Completed
NCT01357512 2017-12-02
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
University of Oulu
Phase NA Completed
NCT01156987 2017-03-09
Improved Breast MRI With SWIFT
University of Minnesota
Phase NA Completed
NCT02516995 2016-02-10
FIBROP
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed
NCT02578602 2015-10-19
MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
University of Southern California
Phase 1 Completed